464 top medical experts on Histiocytosis across 48 countries and 30 U.S. states, including 334 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Histiocytosis: General term for the abnormal appearance of histiocytes in the blood. Based on the pathological features of the cells involved rather than on clinical findings, the histiocytic diseases are subdivided into three groups: histiocytosis, langerhans cell; histiocytosis, NON-langerhans-cell; and histiocytic disorders, malignant.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Lymphatic Diseases (4,615) and Narrower Categories: Langerhans-Cell Histiocytosis (1,438), Malignant Histiocytic Disorders (280), Non-Langerhans-Cell Histiocytosis (893).
  4. Clinical Trials ClinicalTrials.gov : at least 72 including 13 Active, 17 Completed, 26 Recruiting


  

        

                    


    Computing Expert Listing ...

);